More about
Mast Cell-Mediated Diseases
News
April 24, 2024
1 min read
Save
Incyte adds to pipeline with acquisition of Escient Pharmaceuticals
Incyte and Escient Pharmaceuticals have entered a definitive agreement under which Incyte will acquire Escient for $750 million, the companies announced in a press release.